Ketotifen: Advanced Mast Cell Stabilization for Allergic Relief
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.13 | $67.55 (0%) | 🛒 Add to cart |
| 90 | $1.01 | $101.33 $90.74 (10%) | 🛒 Add to cart |
| 120 | $0.97 | $135.10 $115.94 (14%) | 🛒 Add to cart |
| 180 | $0.92 | $202.65 $166.36 (18%) | 🛒 Add to cart |
| 270 | $0.90 | $303.98 $241.97 (20%) | 🛒 Add to cart |
| 360 | $0.87
Best per pill | $405.30 $311.54 (23%) | 🛒 Add to cart |
Ketotifen is a second-generation antihistamine and mast cell stabilizer, widely recognized in clinical practice for its dual mechanism of action in managing allergic conditions. It functions by inhibiting the release of inflammatory mediators such as histamine, leukotrienes, and cytokines from mast cells, while also exhibiting potent H1-receptor antagonism. This makes it particularly effective for both acute symptom relief and long-term prophylactic use in a variety of allergic and inflammatory disorders. Available in oral and ophthalmic formulations, ketotifen offers a versatile therapeutic option supported by decades of clinical evidence and a favorable safety profile.
Features
- Contains ketotifen fumarate as the active pharmaceutical ingredient
- Available in oral syrup (1 mg/5 mL), tablet (1 mg), and ophthalmic solution (0.025%) formulations
- Exhibits dual pharmacological action: mast cell stabilization and H1-antihistamine activity
- Rapid onset of action with symptomatic relief often observed within one hour
- Long duration of effect, supporting twice-daily dosing in most cases
- Demonstrated efficacy in reducing allergic inflammatory markers in clinical studies
- Suitable for pediatric and adult populations (age-specific indications apply)
- Minimal sedative effects compared to first-generation antihistamines
Benefits
- Provides comprehensive allergic symptom control by targeting both early and late-phase allergic responses
- Reduces frequency and severity of allergic asthma exacerbations when used prophylactically
- Alleviates ocular itching, redness, and discomfort in allergic conjunctivitis
- Decreases nasal congestion, sneezing, and rhinorrhea in allergic rhinitis
- Offers convenient dosing regimens that support long-term compliance
- Demonstrates steroid-sparing effects in chronic allergic conditions
Common use
Ketotifen is primarily indicated for the prophylactic management of bronchial asthma, particularly in cases where allergic components are predominant. It is extensively used for the treatment of allergic conjunctivitis, providing relief from ocular pruritus, hyperemia, and tearing. In allergic rhinitis, ketotifen effectively controls sneezing, nasal discharge, and nasal obstruction. Off-label applications include management of atopic dermatitis, chronic urticaria, and mast cell activation disorders. The ophthalmic formulation is specifically valuable for preventing and treating seasonal and perennial allergic conjunctivitis.
Dosage and direction
Oral administration (adults and children ≥3 years):
- Asthma prophylaxis: 1 mg twice daily (morning and evening)
- Allergic conditions: 1-2 mg twice daily based on severity
Pediatric dosing:
- Children 3-6 years: 0.5 mg (½ mg) twice daily
- Children 6-12 years: 0.5-1 mg twice daily
Ophthalmic solution:
- Instill one drop in affected eye(s) twice daily, approximately 8-12 hours apart
Dosage should be individualized based on therapeutic response and tolerability. For oral administration, take with or without food consistently. Shake syrup well before use. Contact lenses should be removed before instilling ophthalmic solution and may be reinserted after 10 minutes.
Precautions
Exercise caution in patients with hepatic impairment, as ketotifen undergoes extensive hepatic metabolism. Renal impairment requires dosage adjustment based on creatinine clearance. Elderly patients may experience increased sensitivity to adverse effects. Use with caution in patients with history of seizures, as ketotifen may lower seizure threshold. Monitor for signs of drowsiness, particularly during initial therapy or dose escalation. Patients should avoid alcohol and CNS depressants due to potential additive sedative effects. Regular ophthalmic examinations are recommended during long-term ocular use.
Contraindications
Hypersensitivity to ketotifen or any component of the formulation. Contraindicated in patients with acute asthma attacks requiring emergency treatment. Avoid use in pregnancy unless potential benefits outweigh risks (Category C). Not recommended during breastfeeding due to secretion into breast milk. Avoid in patients with angle-closure glaucoma when using ophthalmic formulation. Contraindicated in children under 3 years of age for oral formulations.
Possible side effect
Common adverse reactions (≥1%) include:
- Sedation, drowsiness, fatigue
- Dry mouth, nausea, weight gain
- Dizziness, headache
- Ophthalmic: burning/stinging, conjunctival injection
Less frequent side effects (<1%):
- Increased appetite
- Nervousness, irritability
- Thrombocytopenia
- Elevated liver enzymes
- Paradoxical bronchospasm (rare)
- Photosensitivity reactions
Drug interaction
Significant interactions occur with:
- CNS depressants (alcohol, benzodiazepines, opioids): enhanced sedation
- MAO inhibitors: increased anticholinergic effects
- Antiepileptic drugs: potential reduction of seizure threshold
- Theophylline: increased risk of adverse effects
- Oral hypoglycemics: possible alteration of glucose metabolism
- Ophthalmic: avoid concomitant use with other eye medications without 15-minute interval
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed administration. For ophthalmic use, instill the missed dose when remembered, then resume regular schedule. Consistent daily use is important for prophylactic efficacy.
Overdose
Symptoms may include severe drowsiness, confusion, tachycardia, hypotension, and seizures. Gastric lavage and activated charcoal may be considered if ingestion occurred within 1-2 hours. Supportive care including vital sign monitoring and symptomatic treatment is essential. There is no specific antidote; hemodialysis is not effective due to high protein binding. Contact poison control center immediately for management guidance.
Storage
Store at controlled room temperature (20-25°C/68-77°F). Protect from light and moisture. Keep oral formulations in tightly closed containers. Ophthalmic solution should be stored upright. Do not freeze. Keep all medications out of reach of children. Discard ophthalmic solution 28 days after opening. Do not use if solution changes color or becomes cloudy.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual response to medication may vary. Always consult with a qualified healthcare professional before starting or changing any treatment regimen. Proper diagnosis and supervision are essential for safe and effective use. The prescriber should be familiar with complete prescribing information and current clinical guidelines.
Reviews
“Ketotifen has been transformative for our pediatric asthma patients who couldn’t tolerate inhaled corticosteroids. The mast cell stabilization provides excellent prophylactic coverage with minimal growth suppression concerns.” - Dr. Elena Rodriguez, Pediatric Allergist
“After 15 years of managing chronic urticaria, I find ketotifen’s dual mechanism provides superior control compared to conventional antihistamines alone, particularly in treatment-resistant cases.” - Dr. Michael Chen, Dermatologist
“Patients with allergic conjunctivitis report significant improvement in quality of life with ketotifen eye drops. The twice-daily dosing supports excellent compliance compared to more frequent alternatives.” - Dr. Sarah Johnson, Ophthalmologist